From the aThoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY; bDepartment of Colorectal Surgery, Cleveland Clinic Foundation, Weston, FL
*Correspondence address: Valerie W Rusch, MD, FACS, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065. email: [email protected]
Received and Revised June 19, 2020; Accepted June 23, 2020.
Members of the American College of Surgeons COVID-19 Communications Committee, Board of Regents, and Officers are listed in the Appendix.
Disclosure Information: Nothing to disclose.
Disclosures outside the scope of this work: Dr Rusch receivesgrantmoney for institutional clinical trials from Genelux, Inc andGenentech, and receives travel reimbursement for robotic mentoring fromIntuitive Surgical. Dr Rusch is Co-Chair for the Thoracic Malignancy Steering Committee, National Cancer Institute and Member, Data Safety Monitoring Committee, MARS2 Trial (UK). Dr Wexner is a paid consultant for Intuitive, Karl Storz, Stryker, Medtronic, Takeda, and Regentys, receives royalties for intellectual property licenses from Intuitive, Medtronic, Karl Storz Endoscopy, and Unique Surgical Innovation, and holds stock options for consultancy with Regentys, LifeBond, Pragma, and Renew Med.
Support: Dr Rusch's work is supported in part by National Institutes of Health/National Cancer Institute Cancer Center Support Grant P30 CA008748.
